
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm, with a strong brand mix and a significant presence in both North America and international markets. The company is facing cost pressures, particularly in the second quarter of 2026, but has strategies in place to mitigate these costs through productivity efforts, pricing adjustments, and renegotiating supplier contracts. Despite a softer market in May, Kimberly-Clark is expected to deliver solid organic sales and earnings growth in the following years, driven by new product innovation and increased merchandising efforts.
Bears say
Kimberly-Clark is facing potential headwinds due to spiking resin costs, with a projected risk of $0.70-0.80 to 2027 EPS. Higher domestic freight costs may also be a risk. The company's recent KVUE acquisition is expected to initially dilute EPS, but there is potential for significant upside in 2028 through identified productivity and synergy savings. The company is already working to identify these savings through combined distribution and logistics, shared procurement, and accelerated top-line growth opportunities, particularly in emerging markets like India.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares